Pharmaceutical conferences 2009 September

August 27, 2009

Conference Name: The British Pharmaceutical Conference
Email: alyons@health-links.co.uk
Website: http://www.bpc2009.org/
Date: 6th September 2009 – 9th September 2009
Channel– Pharmaceutical

Conference Name: I22nd Annual European Haemophilia Consortium Conference 2009
Email: aiste@balticconference.com
Website: http://www.ehc2009.eu/
Date: 11th September 2009 – 13th September 2009
Channel– Pharmaceutical

Conference Name: 38th Annual Meeting of the American College of Clinical Pharmacology
Email: SUE@ACCP1.org
Website: http://www.accp1.org/cgi-bin/htmlos.cgi/001395.1.3318652372234802535/accp2007/subpage.html
Date: 13th September 2009 – 15th September 2009
Channel– Pharmaceutical

Conference Name: Twelfth Annual Land O’Lakes Conference on Drug Metabolism/Applied Pharmacokinetics
Email: jedemuth@pharmacy.wisc.edu
Website: http://www.pharmacy.wisc.edu/esp/drugmetabolismconference
Date: 14th September 2009 – 18th September 2009
Channel- Pharmaceutical

Conference Name: Computational Systems Biology and Dose Response Modeling Workshop
Email: jgalbo@thehamner.org
Website: http://www.thehamner.org/education-and-training/current-course-offerings.html
Date: 14th September 2009 – 18th September 2009
Channel– Pharmaceutical

Conference Name: 2009 PDA/FDA Joint Regulatory Conference
Email: neal@pda.org
Website: http://www.pda.org/pdafda2009
Date: 16th September 2009 – 18th September 2009
Channel– Pharmaceutical

Conference Name: Rosenšn Meeting 2009: DMPK Aspects of Drug Combinations
Email: jenny.hagberg@lakemedelsakademin.se
Website: http://www.swepharm.se/rosenon2009
Date: 17th September 2009 – 19th September 2009
Channel– Pharmaceutical

Conference Name: 8th Congress of the Baltic Association of Dermatovenereologists
Email: info@badv2009.com
Website: http://www.badv2009.com/home
Date: 17th September 2009 – 19th September 2009
Channel– Pharmaceutical

Conference Name: PDA Discussion Forum: Implementing Rapid Microbiology Methods
Email: info@pda.org
Website: http://www.pda.org/MainMenuCategory/GlobalEventCalendarandRegistration/European-Events/PDA-Discussion-Forum-Implementing-Rapid-Microbiology-Methods.aspx
Date: 21st September 2009
Channel– Pharmaceutical

Conference Name: Workshops on Concepts and Applications of Population based In Vitro – In Vivo Extrapolation of ADME Properties
Email: events@simcyp.com
Website: http://www.simcyp.com/ProductServices/Workshops/
Date: 21st September 2009 – 25th September 2009
Channel- Pharmaceutical

Conference Name: Handling Failures in Sterile Manufacturing
Email: stuermer@concept-heidelberg.de
Website: http://www.gmp-compliance.org/eca_seminar_6106.html
Date: 22nd September 2009 – 23rd September 2009
Channel– Pharmaceutical

Conference Name: Recent Developments in Wound Management: Intelligent Biomaterials to Novel Antimicrobials
Email: events@rpsgb.org
Website: http://www.rpsgb.org/pdfs/sciconf090924.pdf
Date: 24th September 2009
Channel– Pharmaceutical

Conference Name: GMP and FDA Compliance in Pharmaceutical Development and IMP Manufacturing
Email: bach@concept-heidelberg.de
Website: http://www.gmp-compliance.org/eca_seminar_6014.html
Date: 24th September 2009 – 25th September 2009
Channel– Pharmaceutical

Conference Name: Together! Cultural Connections for Quality Care at the End of Life
Email: conference@conlog.com.au
Website: http://www.conlog.com.au/palliativecare2009
Date: 24th September 2009 – 27th September 2009
Channel– Pharmaceutical

Conference Name: 1st World Conference on Physico-Chemical Methods in Drug Discovery and Development
Email: office@iapchem.org
Website: http://www.iapchem.org/
Date: 27th September 2009 – 1st October 2009
Channel– Pharmaceutical

Conference Name: Supporting Pharmacists in Delivering Enhanced Services
Email: events@rpsgb.org
Website: http://www.rpsgb.org/pdfs/sciconf090928.pdf
Date: 28th September 2009
Channel– Pharmaceutical

Conference Name: Property Measurement and Testing of Powders for Pharmaceutical/Neutraceutical Production
Email: wolfson-enquiries@gre.ac.uk
Website: http://www.gre.ac.uk/wolfsoncentre/events/pharmaconference
Date: 29th September 2009
Channel– Pharmaceutical

Conference Name: The QbD/PAT Conference 2009
Email: weidemaier@concept-heidelberg.de
Website: http://www.pat-conference.org/
Date: 29th September 2009 – 1st October 2009
Channel– Pharmaceutical

Conference Name: ICH Q7 Auditor Training Course
Email: ludwig@concept-heidelberg.de
Website: http://www.ichq7-week.org/
Date: 30th September 2009 – 2nd October 2009
Channel– Pharmaceutical

Advertisements

Government Approves Drugs & Cosmetics Amendment Bill in India

July 21, 2008

India boasts of over 80 US FDA-approved plants, the largest number in any country other than the US. But even as these plants are said to be in compliance with the exacting standards set by the US FDA, there is absolutely no guarantee that all of India’s over 20,000 pharmaceutical manufacturing units relentlessly employ the good manufacturing practices (GMP), as revised by India’s drug regulator some three years ago. The fact that some hundred odd inspectors across the country are supposed to verify at frequent intervals the GMP compliance of these 20,000 units itself tells the story.

That is just about the plant quality and exactitude of manufacturing processes many Indian drug units follow. More precarious are the systems of material sourcing (procurement of active pharmaceutical ingredients or bulk drugs). Over 350 bulk drugs are indigenously manufactured and some 200, which include many that are also indigenously manufactured, are imported from China and Eastern Europe, among others, even as the country is also a major exporter of bulk drugs.

The quality of pharmaceutical products could also degenerate owing to inept handling and poor storage facilities at chemist shops and other retail outlets. It is obvious that large number of pharmacy stores in India care a damn for the good pharmacy practices (GPP) prescribed by the government. Storage requirements of biological products, intravenous fluids and vaccines should ideally be more stringent (with specified temperature controls etc.), but there are serious doubts as to whether these requirements are strictly and invariably met. While public sector healthcare centres are a sorry spectacle, even the private sector is largely going scot-free for laxity on this front.

Regulatory experts in India have, in the last few years, turned increasingly vocal on the need for bolstering pharmaco-vigilance (the regulatory term for monitoring, documenting and auditing of adverse reactions caused by new drugs in the years shortly after their market launch). Although some guidelines for adverse drug reaction (ADR) monitoring were issued a few years ago, it is indubitable that these are not followed in right earnest.

ComplianceOnline is bringing one day conference on Complying with GMP and cGMP Requirements – Streamlining Quality Assurance & FDA Compliance”

Source: Business Standard